My skin has even gotten better
As of January this year, California, New Hampshire, Pennsylvania and South Carolina ended Medicaid GLP-1 drug coverage for weight loss, and Michigan started restricting coverage to people classified as morbidly obese, meaning they have a body mass index above 40
Direct Program Eligibility : For those opting for Ivm's direct programs, eligibility is determined instantly with no waiting period
Consider waiting for retatrutide if: You have severe obesity (BMI 40) and specifically need the difference between 15% and 28%+ weight loss a gap that matters clinically when 15% still leaves you in a high-risk range
So many of my patients are looking for natural solutions for GLP-1 support, which is why Im so proud of this breakthrough formulation
The clinical trial results so far are very strong